PQP — Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System Class III

FDA Device Classification

FDA product code PQP covers "Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System", a Class III medical device. Submissions are reviewed by the Unknown panel.

Classification Details

Product Code
PQP
Device Class
Class III
Regulation Number
Submission Type
Review Panel
PA
Medical Specialty
Unknown
Implant
No

Definition

A next generation sequencing (NGS) oncology panel is a device used for the qualitative detection of germline or somatic variants in one or more cancer-related genes. The device is intended to be used on DNA or RNA isolated from human clinical specimens.